Anonymous
Guest
Anonymous
Guest
It's time for big changes at Cubist. Stock is down to 60.85 off it's high of 82.12. This group of clowns has wiped out 1/3 of shareholder value. MB should be voted out as CEO at next proxy meeting. Cubist needs a new set of eyes for the next phase of growth. Sales are stagnant, innovation is lagging and vision is blurred. The only thing that can save the company is a merger with a Pfizer, Merck or J&J. Management has tried to buy it's way to shareholder value but these acquisitions have been just a band aid for lack of sales. The investor community has been waiting on returns to justify the high P/E and it's not happening, eventually you have to deliver or look at a merger to bring back shareholder value. This group is lucky Carl Icahn doesn't own a substantial stake in this company, we need some activist shareholders. When your proxy comes let your voice be heard!